"Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.

BACKGROUND Klebsiella pneumoniae isolates harboring the K. pneumoniae carbapenemase gene (bla(KPC)) are creating a significant healthcare threat in both acute and long-term care facilities (LTCFs). As part of a study conducted in 2004 to determine the risk of stool colonization with extended-spectrum cephalosporin-resistant gram-negative bacteria, 12 isolates of K. pneumoniae that exhibited nonsusceptibility to extended-spectrum cephalosporins were detected. All were gastrointestinal carriage isolates that were not associated with infection. METHODS Reassessment of the carbapenem minimum inhibitory concentrations using revised 2011 Clinical Laboratory Standards Institute breakpoints uncovered carbapenem resistance. To further investigate, a DNA microarray assay, PCR-sequencing of bla genes, immunoblotting, repetitive-sequence-based PCR (rep-PCR) and multilocus sequence typing (MLST) were performed. RESULTS The DNA microarray detected bla(KPC) in all 12 isolates, and bla(KPC-3) was identified by PCR amplification and sequencing of the amplicon. In addition, a bla(SHV-11) gene was detected in all isolates. Immunoblotting revealed "low-level" production of the K. pneumoniae carbapenemase, and rep-PCR indicated that all bla(KPC-3)-positive K. pneumoniae strains were genetically related (≥98% similar). According to MLST, all isolates belonged to sequence type 36. This sequence type has not been previously linked with bla(KPC) carriage. Plasmids from 3 representative isolates readily transferred the bla(KPC-3) to Escherichia coli J-53 recipients. CONCLUSIONS Our findings reveal the "silent" dissemination of bla(KPC-3) as part of Tn4401b on a mobile plasmid in Northeast Ohio nearly a decade ago and establish the first report, to our knowledge, of K. pneumoniae containing bla(KPC-3) in an LTCF caring for neurologically impaired children and young adults.

[1]  P. Nordmann,et al.  Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases , 2011, Journal of Clinical Microbiology.

[2]  Carmen Torres,et al.  Outbreak caused by a multi-resistant Klebsiella pneumoniae strain of new sequence type ST341 carrying new genetic environments of aac(6')-Ib-cr and qnrS1 genes in a neonatal intensive care unit in Spain. , 2010, International journal of medical microbiology : IJMM.

[3]  R. Bonomo,et al.  Evaluation of Updated Interpretative Criteria for Categorizing Klebsiella pneumoniae with Reduced Carbapenem Susceptibility , 2010, Journal of Clinical Microbiology.

[4]  J. Quinn,et al.  Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2 Gene , 2010, Emerging infectious diseases.

[5]  M. Adams,et al.  Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. , 2010, The Journal of antimicrobial chemotherapy.

[6]  Robert A. Bonomo,et al.  Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.

[7]  Y. Carmeli,et al.  The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. Kaye,et al.  Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  P. Nordmann,et al.  Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and KPC Carbapenemases , 2010, Antimicrobial Agents and Chemotherapy.

[10]  L. Rice,et al.  Evaluation of a Commercial Microarray System for Detection of SHV-, TEM-, CTX-M-, and KPC-Type β-Lactamase Genes in Gram-Negative Isolates , 2010, Journal of Clinical Microbiology.

[11]  R. Bonomo,et al.  Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. , 2009, The Journal of antimicrobial chemotherapy.

[12]  J. Campos,et al.  Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. , 2009, The Journal of antimicrobial chemotherapy.

[13]  P. Tolomeo,et al.  Epidemiology of Antimicrobial Resistance among Gram-Negative Organisms Recovered from Patients in a Multistate Network of Long-Term Care Facilities , 2009, Infection Control & Hospital Epidemiology.

[14]  Y. Carmeli,et al.  Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258 , 2009, Antimicrobial Agents and Chemotherapy.

[15]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[16]  M. Adams,et al.  Rapid Determination of Quinolone Resistance in Acinetobacter spp , 2009, Journal of Clinical Microbiology.

[17]  M. Adams,et al.  Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. , 2009, The Journal of antimicrobial chemotherapy.

[18]  P. Edelstein,et al.  Specificity of Ertapenem Susceptibility Screening for Detection of Klebsiella pneumoniae Carbapenemases , 2009, Journal of Clinical Microbiology.

[19]  E. D’Agata,et al.  The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  S. Pournaras,et al.  Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory , 2008, Journal of Clinical Microbiology.

[21]  D. Paterson,et al.  Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound , 2008, Journal of Clinical Microbiology.

[22]  E. S. Moland,et al.  Surveillance of Community-Based Reservoirs Reveals the Presence of CTX-M, Imported AmpC, and OXA-30 β-Lactamases in Urine Isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. Community , 2008, Antimicrobial Agents and Chemotherapy.

[23]  L. Rice,et al.  The KQ Element, a Complex Genetic Region Conferring Transferable Resistance to Carbapenems, Aminoglycosides, and Fluoroquinolones in Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.

[24]  K. Ko,et al.  Clonal Dissemination of Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella pneumoniae Isolates in a Korean Hospital , 2008, Journal of Korean medical science.

[25]  J. Quinn,et al.  Genetic Structures at the Origin of Acquisition of the β-Lactamase blaKPC Gene , 2008, Antimicrobial Agents and Chemotherapy.

[26]  J. Patel,et al.  Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae , 2007, Journal of Clinical Microbiology.

[27]  Ronald N. Jones,et al.  Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). , 2006, Diagnostic microbiology and infectious disease.

[28]  D. Ecker,et al.  Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center , 2006, Antimicrobial Agents and Chemotherapy.

[29]  Sylvain Brisse,et al.  Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates , 2005, Journal of Clinical Microbiology.

[30]  P. Toltzis.  Antibiotic-resistant gram-negative bacteria in hospitalized children. , 2004, Clinics in laboratory medicine.

[31]  P. Toltzis.  Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit. , 2003, Minerva pediatrica.

[32]  P. Toltzis,et al.  Descriptive and molecular epidemiology of Gram-negative bacilli infections in the neonatal intensive care unit , 2003, Current opinion in infectious diseases.

[33]  C. Donskey,et al.  Cefotaxime‐Resistant Bacteria Colonizing Older People Admitted to an Acute Care Hospital , 2003, Journal of the American Geriatrics Society.

[34]  L. Rice,et al.  Antibiotic-resistant gram-negative organisms in pediatric chronic-care facilities. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  R. Bonomo.  Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[37]  V. Jarlier,et al.  Extended-spectrum beta-lactamases in long-term-care facilities. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  P. Wayne.  PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .

[39]  V. Jarlier,et al.  Extended-spectrum β-lactamases in long-term-care facilities , 2008 .

[40]  Ronald N. Jones,et al.  Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). , 2006, Microbial drug resistance.

[41]  L. Rice,et al.  A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics? , 2002, Microbial drug resistance.